Michael S. Ominsky - Concepedia

Author

Michael S. Ominsky

Also Known As

M Ominsky, M. Ominsky, M. S. OMINSKY, M. S. Ominsky, M.S. Ominsky, M.S. Ominsky⁎, MICHAEL OMINSKY, Michael Ominsky, Michael S Ominsky, Michael S. Ominsky

120

Publications

10.2K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)Radius Health (United States)University of Michigan Harvard University UCB Pharma (United Kingdom)

About

Michael S. Ominsky is an author at Amgen (United States) specializing in medicine, osteoporosis, and osteoarthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	40	3.8K
2	Health Sciences	18	18	1.3K
3	Biomedical Engineering	4	4	85
4	Engineering	2	2	31
5	Applied Physiology	1	1	35

Michael S. Ominsky

Publications

9.6K

Citations

H-Index

Page 1

	Year	Citations
Dickkopf-1 is a master regulator of joint remodeling Danielle Diarra, Marina Stolina, Karin Polzer, Nature Medicine Musculoskeletal ResearchMolecular BiologyMaster RegulatorBiomedical Research	2007	1.3K
Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength Xiaodong Li, Michael S. Ominsky, Qing‐Tian Niu, Journal of Bone and Mineral Research	2008	932
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis Xiaodong Li, Michael S. Ominsky, Kelly Warmington, Journal of Bone and Mineral Research SclerostinImmunologyOrthopaedic SurgeryRat ModelOsteoporosis	2008	773
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia Ji Li, Ildiko Sarosi, Russell C. Cattley, Bone MechanobiologySclerostinDkk1-mediated InhibitionBone Morphogenic ProteinCell Signaling	2006	429
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL Paul J. Kostenuik, Hung Q. Nguyen, James McCabe, Journal of Bone and Mineral Research	2008	428
Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength Michael S. Ominsky, Fay Vlasseros, Jacquelin Jolette, Journal of Bone and Mineral Research	2010	410
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones Michael S. Ominsky, Chaoyang Li, Xiaodong Li, Journal of Bone and Mineral Research	2010	264
Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies Ian R. Reid, Paul D. Miller, Jacques P. Brown, Journal of Bone and Mineral Research	2010	249
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair Mónica Florio, Kannan Gunasekaran, Marina Stolina, Nature Communications	2016	248
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats Xiaodong Li, Kelly Warmington, Qing‐Tian Niu, Journal of Bone and Mineral Research SclerostinImmunologyOrthopaedic SurgeryOsteoporosisBone Disease	2010	233

Page 1